Inventor · disambiguated record
Gregory John Hollingworth
Also filed as: HOLLINGWORTH GREGORY J · HOLLINGWORTH GREGORY JOHN · HOLLINGWORTH Gregory
29 granted patents·23 pending applications·404 citations·filing 1997–2023
96Inventor score
Files withMERCK SHARP & DOHME17NOVARTIS AG16COOKE NIGEL GRAHAM4BAYLISS TRACY3BELLENIE BENJAMIN RICHARD3
Top patents by PatentIndex Score
52 records- 0194US6172077B1Spiro-azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1998·Granted Jan 9, 2001·149 cites·15 claims
- 0290US6518273B12-aryl indole derivative as antagonists of tachykininsMERCK SHARP & DOHME·Filed 2000·Granted Feb 11, 2003·31 cites·6 claims
- 0386US5952315AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1997·Granted Sep 14, 1999·34 cites·5 claims
- 0486US2025059181A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0584US6476045B2Azaindole derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2001·Granted Nov 5, 2002·16 cites·29 claims
- 0683US11541056B23-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivativesNOVARTIS AG·Filed 2019·Granted Jan 3, 2023·2 cites·13 claims
- 0781US9949979B2Use of inhibitors of the activity or function of PI3KNOVARTIS AG·Filed 2012·Granted Apr 24, 2018·9 cites·9 claims
- 0876US12441733B2Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitorsNOVARTIS AG·Filed 2023·Granted Oct 14, 2025·0 cites·12 claims
- 0976US2022267318A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1074US8653092B2Tetrahydro-pyrido-pyrimidine derivativesCOOKE NIGEL GRAHAM·Filed 2011·Granted Feb 18, 2014·2 cites·21 claims
- 1173US11613543B2Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Mar 28, 2023·1 cites·14 claims
- 1273US5929054AUse of NK-1 receptor antagonists for treating sexual dysfunctionsMERCK SHARP·Filed 1997·Granted Jul 27, 1999·41 cites·3 claims
- 1372US7442701B2Amino-heterocycles as VR-1 antagonists for treating painMERCK SHARP & DOHME·Filed 2003·Granted Oct 28, 2008·6 cites·10 claims
- 1470US6953792B2Cyclohexyl derivatives and their use as therapeutic agentsMERCK & CO INC·Filed 2001·Granted Oct 11, 2005·6 cites·17 claims
- 1570US2023398117A13-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide DerivativesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1670US2020392132A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1769US7105507B2Cyclohexane derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2001·Granted Sep 12, 2006·4 cites·19 claims
- 1868US2019218217A1Tetrahydro-Pyrido-Pyrimidine Derivatives as PI3Kdelta inhibitorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1967US5977104AUse of NK-1 receptor antagonists for treating bipolar disordersMERCK SHARP & DOHME·Filed 1998·Granted Nov 2, 1999·29 cites·4 claims
- 2066US2019040061A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2165US6114315AUse of NK-1 receptor antagonists for treating major depressive disorders with anxietyMERCK SHARP & DOHME·Filed 1998·Granted Sep 5, 2000·26 cites·4 claims
- 2265US2018265509A1Tetrahydro-Pyrido-Pyrimidine DerivativesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2363US10112926B2Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitorsBELLENIE BENJAMIN RICHARD·Filed 2014·Granted Oct 30, 2018·1 cites·14 claims
- 2463US9862711B2Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitorsBELLENIE BENJAMIN RICHARD·Filed 2014·Granted Jan 9, 2018·1 cites·20 claims
- 2562US9499536B2Tetrahydro-pyrido-pyrimidine derivativesCOOKE NIGEL GRAHAM·Filed 2014·Granted Nov 22, 2016·0 cites·8 claims
- 2661US7285563B2Heteroaromatic urea derivatives as VR-1 receptor modulators for treating painBROWN REBECCA ELIZABETH·Filed 2003·Granted Oct 23, 2007·5 cites·12 claims
- 2761US2017267678A1Tetrahydro-Pyrido-Pyrimidine DerivativesCOOKE NIGEL GRAHAM·Filed 2017·Application pending·0 cites
- 2860US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 2959US2017022199A1Tetrahydro-Pyrido-Pyrimidine DerivativesCOOKE NIGEL GRAHAM·Filed 2016·Application pending·0 cites
- 3057US2024216513A1Fatty acid-bifunctional degrader conjugates and their methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3156US6071927ASpiro-piperidine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1997·Granted Jun 6, 2000·13 cites·24 claims
- 3250US2022315578A1Brd9 bifunctional degraders and their methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3349US10004732B2Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitorsBELLENIE BENJAMIN RICHARD·Filed 2014·Granted Jun 26, 2018·0 cites·14 claims
- 3448US5925627AUse of NK-1 receptor antagonists for treating movement disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 20, 1999·7 cites·11 claims
- 3548US2018243297A1Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitorsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3648US2022387602A1Bifunctional degraders and their methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3746US2007135454A1Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)BAYLISS TRACY·Filed 2004·Application pending·0 cites
- 3845US2005197342A1Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating painFiled 2004·Application pending·0 cites
- 3943US6271230B1Use of NK-1 receptor antagonists for treating cognitive disordersMERCK SHARP & DOHME·Filed 1999·Granted Aug 7, 2001·6 cites·5 claims
- 4043US6100256AUse of NK-1 receptors antagonists for treating schizophrenic disordersMERCK SHARP & DOHME·Filed 1998·Granted Aug 8, 2000·7 cites·11 claims
- 4143US2007078156A1Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of painFLETCHER STEPHEN R·Filed 2004·Application pending·0 cites
- 4241US5919781AUse of NK-1 receptor antogonists for treating substance use disordersMERCK SHARP & DOHME·Filed 1997·Granted Jul 6, 1999·5 cites·6 claims
- 4341US2009233947A12,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1)BAYLISS TRACY·Filed 2006·Application pending·0 cites
- 4441US2006154930A1Substituted amino heterocycles as vr-1 antagonists for treating painBROWN REBECCA E·Filed 2004·Application pending·0 cites
- 4540US7253205B2Gem-disubstituted cyclohexane derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Aug 7, 2007·0 cites·16 claims
- 4640US2014249139A1Quinazoline DerivativesFURET PASCAL·Filed 2012·Application pending·0 cites
- 4740US2011152242A12,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 AntagonistsBAYLISS TRACY·Filed 2006·Application pending·0 cites
- 4838US6087348AUse of NK-1 receptor antagonists for treating stress disordersMERCK SHARP & DOHME·Filed 1999·Granted Jul 11, 2000·3 cites·15 claims
- 4938US2001039286A12-aryl indole derivatives and their use as therapeutic agentsFiled 2001·Application pending·0 cites
- 5037US2007213332A1Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1)BURKAMP FRANK·Filed 2005·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →